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Despite the volume of studies written after the initial report by Hildebrand (1895) on Warthin's tumour
(WT), its aetiopathogenesis continues to be an unresolved and controversial question. Many different
genetic and/or environmental aetiological factors seem to act on heterotopic ductal inclusions and may
give rise to WT following an unknown tumorigenic event. Recent studies discussed the importance of
immunological reactions during the formation of the tumour. A hypersensitive/allergic reaction may play
a role in epithelial proliferation and may stimulate the reactivity of the germinal centres in the lymphoid
stroma as showed at histological examination. The aim of this study was to inform readers of the current
understanding of possible risk factors with a suggested aetiological role in Warthin's tumorigenesis.
From 2001 to 2011, a total of 342 patients with benign salivary neoplasm were admitted in the
Department of Maxillofacial Surgery of the University of Naples “Federico II”. A histological diagnosis of
WT was made in 115 of the patients (33.6%); these were retrospectively investigated in our study.
Correlation between the onset of WT and positivity for autoimmune diseases and smoking habits was
calculated. The incidence rate of autoimmune thyroiditis in our series (9.5%) was signiﬁcantly greater
than that of the general population (0.58%) (p < 0.001). Analysis of our series and review of the literature
support the hypothesis that this tumour is the result of an autoimmune reaction. Further studies and
larger series are required to conﬁrm this hypothesis and investigate the role of other aetiological factors
in WT genesis.
© 2014 European Association for Cranio-Maxillo-Facial Surgery. Published by Elsevier Ltd. All rights
reserved.1. Introduction
Warthin's tumour (WT), also known as papillary cystadenoma
lymphomatosum is a fairly common tumour. It was ﬁrst described
by Hildebrand in 1895, when he described this disease as a variant
of a lateral cyst of the neck. In 1910, Albrecht and Arzt reported two
tumours of the upper neck region which they described as
‘confused tissue’ of the entodermal pharyngeal anlage, particularlyacial surgery, University of
. Tel.: þ39 0817462176.
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axillo-Facial Surgery. Published bythat of salivary glands in the lymph nodes (Albrecht and Arzt, 1910).
They called them papillary cystadenomas in lymph nodes. In 1929,
Warthin described similar cases and they were renamed after him.
Warthin's tumours make up 14e30% of parotid tumours. Yoo et al.
in their series, found 90% within the parotid, 7.6% in cervical lymph
nodes, and 2.3% in the submandibular gland (Yoo et al., 1994).
Histologically, they are composed of bilayered oncocytic and
basaloid epithelium-forming cystic structures, papillae and glands,
accompanied by a dense lymphoid stroma. Recent studies have
shown that the epithelial component is polyclonal and does not
exhibit clonal allelic losses, suggesting that this tumour is not a true
neoplasm (Arida et al., 2005). These tumours have a male pro-
pensity and are more frequently multicentric than other salivaryElsevier Ltd. All rights reserved.
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mours. They can occur unilaterally or bilaterally, metachronously or
synchronously (Laane et al., 2002).
About a century after its ﬁrst description, the aetiopathogenesis
of this tumour is still mostly unknown. In most surveys, the
assumption prevails that this tumour has its origin in heterotopic
salivary parenchymal or ductal inclusions in the intra- and peri-
glandular lymph nodes during the embryonic development of the
parotid gland (Thompson and Bryant, 1950; Azzopardi and Hou,
1964). Many different genetic and/or environmental aetiological
factors seem to act on these epithelial inclusions and may give rise
to Warthin's tumour following an unknown tumorigenic event.
Other studies have discussed the importance of immunological
reactions during the formation of the tumour (Allegra,1971; Ogawa
et al., 1990; Gallo and Bocciolini, 1997). It is possible that some
hypersensitive/allergic reaction may play a role in epithelial pro-
liferation and may stimulate the reactivity of the germinal centres
in the lymphoid stroma as seen on histological examination. The
aim of this study was to inform readers of the current under-
standing of possible risk factors with a suggested aetiological role in
Warthin's tumorigenesis.
2. Material and methods
From 2001 to 2011, a total of 342 patients with benign major
salivary gland neoplasm were admitted to the Department of
Maxillofacial Surgery of the University of Naples “Federico II”. One
hundred and ﬁfteen patients (33.6%) were histologically diagnosed
as Warthin's tumour and retrospectively investigated in our study
(Fig. 1). All the data was inserted into our clinic database and
analysed. The Patients' ages range was 38e79 years (mean age
58.47); and the male/female ratio was 2.5:1, with 33 females
(28.9%) and 82 males (71.1%) included in the study.
All patients included in the study initially presented with a
swelling in the parotid region which was diagnosed as WT and
surgically removed. Patient data was reviewed and any history of
smoking and/or autoimmune diseases was noted. In all the cases
bilateral parotid ultrasonography (US) or computed tomography
(CT) and ﬁne needle aspiration cytology (FNAC) were performed in
order to conﬁrm the suspected clinical diagnosis. In 110 cases
(82.7%), the surgery performed was extracapsular dissection (ECD);
in 6 cases (4.5%) total parotidectomy; and in 17 cases (12.8%) su-
perﬁcial parotidectomy. The choice of the surgical strategy wasFig. 1. Major salivary gland benign tumour distribution.based on the radiographic evidence of depth of the lesion, a second
occurrence/recurrence after ECD, or presence of homolateral syn-
chronous lesions. Warthin's ECD was carried out with meticulous
dissection immediately outside the tumour capsule. The tumour
was removed with a few millimetres of normal glandular paren-
chyma; facial nerve preservation was obtained in all cases. Data for
the preoperative cytology and the deﬁnitive histological diagnosis
was reviewed. Patients were followed-up for a minimum of 28
months, and a maximum of 60 months (mean 44) in order to
evaluate facial nerve function and determine the recurrence rate.
Correlation between WT onset and positivity for autoimmune
diseases and smoking habits was calculated. Univariate analysis
was performed using Chi-Square test with the SPSS base system,
version 12.0 (SPSS, Chicago, IL, USA). The test used to compare
scientiﬁc results with the outcome research, was the parametric
hypothesis test for one proportion where the null hypothesis
foresees no difference between results of the two groups of
research; the opposing hypothesis, an alternative hypothesis, rep-
resents the signiﬁcant difference between the two groups
(Eurodiab Ace Study Group, 2000; McGrogan et al., 2008).
3. Results
In our series unilateral or bilateral multifocal lesions were
detected in 22 cases (19.1%). A total of 133 parotid operations were
performed in 115 patients. Eighteen (13.5%) patients had further
surgery after metachronous (tumours diagnosed at different times)
homolateral, or contralateral tumour occurrence; four (3.5%) pa-
tients were treated for synchronous lesions (tumours diagnosed at
the same time). In our series a second tumour occurrence/recur-
rence on the same side as the ﬁrst operation (metachronous
homolateral) was observed in two patients (1.7%) (Fig. 2); these
tumours were detected 3 years and 5 years (median 4 years) after
the ﬁrst operation. A sudden partial facial nerve dysfunction due to
surgical treatment was seen in nine cases (6.8%). Among these
patients, eight (6%) had an isolated weakness of the marginal
mandibular branch, and one (0.7%) reported a transient facial
paresis. In all cases facial nerve function recovered within 3
months.
Evaluation of risk factors revealed that 86 (74.8%) patients were
smokers. During the follow-up period 18 patients (15.7%) devel-
oped a metachronous lesion not previously diagnosed, and all of
these (100%) were smokers. Retrospective clinical history analysis
revealed that 11 patients (9.6%) were affected by common auto-
immune diseases; three patients (2.6%) had a story of insulin-
dependent diabetes mellitus; eight (6.9%) patients were affected
by autoimmune thyroiditis. Levels of TSH, thyroid hormones and
anti-thyroid Ab, were abnormal in six cases of hypothyroidism and
in two of hyperthyroidism (Table 1).2
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Fig. 2. Multifocal Warthin tumour.
Table 1
Autoimmune diseases in our series.
Autoimmune diseases n %
Insulin-dependent diabetes mellitus 3 2.6
Autoimmune thyroiditis 8 6.9
Hyperthyroidism 6 5.2
Hypothyroidism 2 1.7
Total 11 9.6
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mellitus, second tumour occurrence/recurrence was observed in
three of the 115 patients (2.6%). Although this percentage is higher
than previous research, the hypothesis test showed no statistical
difference (p ¼ 0.3015).
There were signiﬁcant differences when comparing patients
affected by autoimmune hypothyroidism and hyperthyroidism. In
the ﬁrst case, 2 patients out of 115 (1.7%), compared with 430 out of
100,000 (0.43%) of the general population, had autoimmune hy-
pothyroidism (p ¼ 0.0162). In the second case, 9 patients out of 115
(7.8%), compared with 88 out of 100,000 (0.088%) of the general
population, had autoimmune hyperthyroidism (p < 0.001). Overall,
analysing all the pathologies (autoimmune hypothyroidism and
hyperthyroidism) the percentage of cases (9.5%) is signiﬁcantly
different than the referenced study (McGrogan et al., 2008)
(0.43% þ 0.088% ¼ 0.52%) with p < 0.001.
4. Discussion
Warthin's tumour is the most common monomorphic adenoma
of the major salivary glands, representing about 2e15% of all pa-
rotid tumours.
It can be multifocal: homolateral (20.5% of cases) or bilateral
(6.5% of cases), synchronous or metachronous (Maiorano et al.,
2002). Typically it presents in patients between 35 and 80 years,
but the highest incidence has been reported between 55 and 65
years (Ramírez Ponferrada et al., 1999).
Magnetic resonance imaging (MRI) is undoubtedly the most
accurate means of imaging salivary gland pathology. However, it
has the disadvantage of being expensive and has very long waiting
times. Modern computed tomography (CT) provides a reliable
topographical location of the lesion with lower costs and shorter
waiting times. Moreover, we believe that the association between
CT and FNAC in all our patients provides accurate information on
the location and nature of the lesion.
There is continuing debate about the appropriate extent of
surgery forWT. Malignant transformation is very rare, representing
only 0.3% of all WT (Batsakis, 1987). Recurrence rates, from 5% to
12% have been reported after a limited surgical approach (Lamelas,
1987).
Based on these rates most authors recommended superﬁcial
parotidectomy; however, as suggested by Hatch and Shah (2005),
these may not represent true recurrences, because of the com-
mon multifocal nature (synchronous or metachronous) of these
tumours. It is also possible to miss a synchronous second War-
thin's tumour. Yu et al. in their study, conﬁrm this hypothesis,
they reported a shorter operating time, less risk of facial nerve
damage, less facial deformity, lower incidence of Frey's syn-
drome, and better preservation of the function of the parotid
gland, when they compared ECD of Warthin's tumour in the
parotid gland (n ¼ 61) with those of superﬁcial parotidectomy
(n ¼ 88) (Yu et al., 2004). In our series we performed 110 ECD and
at a mean follow-up time of 42 months we found only two (1.5%)
occurrences/recurrences on the same side of the ﬁrst operation
(Fig. 2).Cystadenolymphomas consist of two components; an epithelial
component, composed of bilayered oncocytic and basaloid
epithelium-forming cystic structures, papillae and glands; and a
variable stroma component, with lymphoid tissue similar to that of
a lymph node. The lymphoid stroma, with germinal centres, con-
sists of small lymphocytes, especially B-lymphocytes. Seifert et al.
(Seifert et al.,1980; Satko et al., 2000; Tarsitano et al., 2014)
observed a variable quantitative proportion between stromal and
epithelial component. They recognized four subtypes: classic
Warthin's tumour (subtype 1); Stroma poor (subtype 2); Stroma
rich (subtype 3); and squamous metaplasia (subtype 4).
Despite the volume of studies written after the initial report by
Hildebrand (1895) on WT, its pathogenesis continues to be an un-
resolved and controversial question. The favourite theory is that it
arises from proliferative salivary gland ductal cells, which were
entrapped in parotid lymph nodes (Teymoortash and Werner,
2005). The ductal metaplasia, which is another unique feature of
this pathologic lesion, would be induced by some aetiological fac-
tors but the tumorigenesis mechanisms are still unknown.
Carcinogens in tobacco smoke seem to be an important risk
factor for the onset ofWarthin's tumour. Kotwall stated that the risk
of smokers developingWarthin's tumour is eight times higher than
that of non-smokers (Kotwall, 1992). A strong association with
smoking has been reported for both synchronous and metachro-
nous bilateral lesions: smoking would act by the direct action of
carcinogenic substances that are mixed in the saliva passing in a
retrograde fashion into the salivary duct and leading to ductal
metaplasia (Peter Klussmann et al., 2006;Giannone et al., 2008; Jia
et al., 2012; Deveer et al., 2013). Our series conﬁrms the increased
risk. From 2001 to 2011, 86 patients (74.8%) with Warthin's tumour
were smokers and 15 of the patients (13.04%) requiring reoperation
for multiple bilateral lesion were heavy smokers. The close corre-
lation between this neoplasm and smoking could explain the pro-
gressive increase in its incidence in females, indisputably linked to
the increase in modern society of women smokers.
Batori et al. (2002) noticed that ionizing radiation represents a
decisive factor in the appearance of this tumour. This theory is
conﬁrmed by the high incidence of this tumour among the Japa-
nese people who survived the atomic bomb explosions and among
subjects irradiated at young age for treatment of ringworm.
Teymoortash et al. (2001) performed immunohistochemical
analysis on tissue samples of cystadenolymphoma, pleomorphic
adenoma and normal samples of the parotid gland, searching for
oestrogen and progesterone receptors. Positivity for progesterone
receptors was found in six out of nine samples tested. The presence
of progesterone receptors in the salivary duct system of the normal
parotid gland is expected to inﬂuence the regulation of water and
electrolyte transport. The detection of sex hormone receptors in
cystadenolymphoma might give evidence of a hormone depen-
dence of this tumour that could explain the higher proportion of
men affected by the disease.
The role of virus infection as a risk factor for Warthin's tumour
development was studied in detail by many of the authors. The
presence of RNA or DNA viral genome in saliva, suggests that non-
sexual transmission may be associated with latent infection of the
salivary gland.
Dalpa et al. (2008) investigated the presence of human herpes
virus 8 (HHV-8) in a series of 43 Warthin's tumours of the salivary
gland. HHV-8 DNAwas detected in 19 out of 43 (44%) salivary gland
tumour samples, suggesting a signiﬁcant role of the virus in the
aetiopathogenesis of the disease. Teymoortash et al. (2013) inves-
tigated 40 Warthin's specimens by PCR followed by in situ hy-
bridization but no relationship between human papilloma virus
and Warthin's tumour was found. Laane et al. (2002) found that
none of the 13 Warthin's specimens tested for the presence of
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positive.
All these authors have shown varying strengths of association
between several factors and Warthin's tumour, but what is not yet
clear is the pathogenic mechanism underlying its origin. The
lymphoid stroma could be the key to answering this question. The
reactive nature of lymphoid stroma in WT and its possible activa-
tion and modulation by epithelial cells, have suggested the
involvement of autoimmune reactions in the mechanisms
responsible for tumour growth.
The association between WT and autoimmune disease was ﬁrst
hypothesized by Allegra in 1971 (1971). On the basis of morpho-
logical analogies between the histological features of WT and those
observed in several organ-speciﬁc immune disorders, particularly
in Hashimoto's thyroiditis and autoimmune disease involving
salivary and lacrimal glands (that is, Sj€ogren syndrome), Allegra
postulated the involvement of cell-mediated immune mechanisms
of the delayed hypersensitivity type in its pathogenesis.
In 1984 Nikai and Schroeder, using stereologic point-counting
methods at the electron microscopic level, analysed the composi-
tion of lymphoid stroma in two specimens. They found that areas
corresponding to the mantle zone of lymphoid follicles contain
83.0% small, and 15.8% medium/large lymphocytes. Authors sug-
gested the present data seems to be in accordance with the spec-
ulation that the lymphoid stroma of adenolymphoma represents an
immune reaction.
In 1990, Ogawa et al. used immunohistochemical methods to
demonstrate the expression of MHC class II antigens on the
epithelial component of WT, suggesting that these cells possess
the potential to act as antigen-presenting cells with the capa-
bility of activating lymphoid stroma in WT (Ogawa et al., 1990).
Moreover, Gallo and Bocciolini have tried to clarify the possible
role of immune mechanisms in the pathogenesis of WT, search-
ing for a possible association with autoimmune pathologies
(Gallo and Bocciolini, 1997). They retrospectively investigated
clinical records of 140 patients affected by Warthin's tumour,
compared with those of 380 patients affected by pleomorphic
adenoma, and found a higher incidence of autoimmune disor-
ders, particularly organ-speciﬁc disease (i.e. insulin-dependent
diabetes mellitus, Hashimoto's thyroiditis, autoimmune hyper-
thyroidism and hypothyroidism) in Warthin's tumour patients
than in pleomorphic adenoma patients (23% vs 3%; relative risk:
8.69; p < 0.0001).
Recently, in 2013, Aga et al., on the basis of the same aetiopa-
thogenic hypothesis, indicated a possible involvement of Warthin's
tumour with immunoglobulin G4-related diseases (IgG4-RDs) (Aga
et al., 2013). IgG4-RDs comprises a recently recognized group of
diseases (autoimmune pancreatitis, sclerosing dacryoadenitis and
cholangitis, sialadenitis, lymphadenopathy, retroperitoneal ﬁbrosis,
tubulointerstitial nephritis, and abdominal aortic aneurysms)
characterized by elevated serum IgG4 levels and prominent lym-
phoplasmacytic inﬁltration by IgG4-positive cells into multiple
organs. These data could be further evidence suggesting that an
immune reactionwith an unknown inﬂammatory background may
be involved in the aetiopathogenesis of Warthin's tumour.
5. Conclusions
Analysis of our results and the review of the literature support
the hypothesis that this tumour is the result of an autoimmune
reaction. Histopathological similarities and close clinical correla-
tion with other organ-speciﬁc autoimmune diseases are the
strongest evidence in support of this hypothesis. Lymphatic-rich
stroma appears to play a key role in the genesis of WT. The
tumour seems to originate from interactions between the germinalcentres in the lymphoid stroma and the epithelial component of the
salivary ducts. There is scientiﬁc evidence demonstrating that these
cells, following chemical insult from tobacco and viral (EBV) insults,
act as antigen-presenting cells expressing MHC class II antigens on
surfaces. In this way these cells would act as activators and mod-
ulators of the autoimmune response in the germinal centres of the
lymphatic-rich stroma.
Further studies and larger series are required to conﬁrm this
hypothesis and to investigate the role of the other aetiological
factors in the development or progression of the lesion.References
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